Formulated the multi-microgrid (MMG) operation as a transaction commitment problem. • Designed a two-stage robust optimization based MMG coordinated operation approach. • Described discrete feature of energy interactive behaviour among multiple microgrids. • Mitigated the disturbances of uncertainties in renewable energy. • Reduced frequent energy exchange between the MMG and the grid.
Aim
To investigate the effects of sodium butyrate (NaB) and lipopolysaccharide (LPS) on gingival epithelial barrier.
Material and methods
We cultured human primary gingival epithelial cells and investigated the effects of NaB and LPS on gingival epithelial barrier and involved mechanisms at in vitro and in vivo levels by immunostaining, confocal microscopy, field emission scanning electron microscopy (FE‐SEM), transmission electronic microscopy (TEM), transepithelial electrical resistance (TEER), FTIC‐dextran flux, flow cytometry, real‐time PCR and Western blot assays.
Results
Our results showed that NaB, rather than LPS, destroyed the epithelial barrier by breaking down cell–cell junctions and triggering gingival epithelial cell pyroptosis with characteristic morphological changes, including swollen cells, large bubbles, pore formation in the plasma membrane and subcellular organelles changes. The upregulated expression of pyroptosis‐related markers, caspase‐3 and gasdermin‐E (GSDME) contributed to this effect. Pyroptosis aroused by NaB is a pro‐inflammatory cell death. Pyroptotic cell death provoked inflammatory responses by upregulation of IL‐8 and MCP‐1, and releasing intracellular contents into the extracellular microenvironment after pyroptotic rupture of the plasma membrane.
Conclusions
Our new findings indicate that butyrate is a potent destructive factor of gingival epithelial barrier and pro‐inflammatory mediator, which shed a new light on our understanding of periodontitis initiation.
Single-atom
nanozymes (SAzymes), with individually isolated metal
atom as active sites, have shown tremendous potential as enzyme-based
drugs for enzymatic therapy. However, using SAzymes in tumor theranostics
remains challenging because of deficient enzymatic activity and insufficient
endogenous H2O2. We develop an external-field-enhanced
catalysis by an atom-level engineered FeN4-centered nanozyme
(FeN4-SAzyme) for radio-enzymatic therapy. This FeN4-SAzyme exhibits peroxidase-like activity capable of catalyzing
H2O2 into hydroxyl radicals and converting single-site
FeII species to FeIII for subsequent glutathione
oxidase-like activity. Density functional theory calculations are
used to rationalize the origin of the single-site self-cascade enzymatic
activity. Importantly, using X-rays can improve the overall single-site
cascade enzymatic reaction process via promoting the conversion frequency
of FeII/FeIII. As a H2O2 producer, natural glucose oxidase is further decorated onto the
surface of FeN4-SAzyme to yield the final construct GOD@FeN4-SAzyme. The resulting GOD@FeN4-SAzyme not only
supplies in situ H2O2 to continuously produce
highly toxic hydroxyl radicals but also induces the localized deposition
of radiation dose, subsequently inducing intensive apoptosis and ferroptosis
in vitro. Such a synergistic effect of radiotherapy and self-cascade
enzymatic therapy allows for improved tumor growth inhibition with
minimal side effects in vivo. Collectively, this work demonstrates
the introduction of external fields to enhance enzyme-like performance
of nanozymes without changing their properties and highlights a robust
therapeutic capable of self-supplying H2O2 and
amplifying self-cascade reactions to address the limitations of enzymatic
treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.